UBS Group AG - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$84,426
-42.7%
78,172
-31.6%
0.00%
Q2 2023$147,335
+54.9%
114,213
+58.5%
0.00%
Q1 2023$95,108
+175.2%
72,051
+212.8%
0.00%
Q4 2022$34,556
-94.8%
23,037
-96.1%
0.00%
Q2 2022$668,000
-24.8%
590,858
+98.9%
0.00%
Q1 2022$888,000
-20.4%
297,055
-29.4%
0.00%
Q4 2021$1,115,000
+1856.1%
420,985
+2559.1%
0.00%
Q3 2021$57,000
-70.2%
15,832
-63.9%
0.00%
Q2 2021$191,000
-82.2%
43,819
-86.1%
0.00%
Q1 2021$1,076,000
+1581.2%
314,749
+802.9%
0.00%
Q2 2020$64,000
-48.4%
34,858
-56.0%
0.00%
Q1 2020$124,000
-72.1%
79,206
-61.9%
0.00%
Q4 2019$445,000
+100.5%
207,839
+74.8%
0.00%
Q3 2019$222,000
-17.8%
118,935
+14.9%
0.00%
Q2 2019$270,000
+76.5%
103,492
+73.4%
0.00%
Q1 2019$153,000
-90.4%
59,685
-91.4%
0.00%
-100.0%
Q4 2018$1,601,000
+8794.4%
696,111
+12330.6%
0.00%
Q3 2018$18,000
-64.0%
5,600
-68.3%
0.00%
Q2 2018$50,000
-96.7%
17,649
-95.8%
0.00%
-100.0%
Q1 2018$1,499,000
+88.8%
423,414
+107.0%
0.00%
Q4 2017$794,000
+2735.7%
204,546
+1739.4%
0.00%
Q3 2017$28,000
-89.9%
11,120
-89.0%
0.00%
Q2 2017$277,000
+1285.0%
101,452
+1575.5%
0.00%
Q1 2017$20,000
+17.6%
6,055
-18.4%
0.00%
Q4 2016$17,000
-22.7%
7,417
+23.6%
0.00%
Q3 2016$22,000
+2100.0%
6,000
+1873.7%
0.00%
Q2 2016$1,000
-87.5%
304
-91.1%
0.00%
Q3 2015$8,0003,4330.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders